Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
- Richard J. MacIsaac, PHD, MBBS, FRACP12,
- Con Tsalamandris, MBBS12,
- Sianna Panagiotopoulos, BSC (HONS), PHD1,
- Trudy J. Smith, BSC, MAPPSC1,
- Karen J. McNeil, MBBS1 and
- George Jerums, MBBS, FRACP, MD12
- 1Endocrinology Unit, Austin Health, Heidelberg, Victoria, Australia
- 2Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
- Address correspondence and reprint requests to Dr. R.J. MacIsaac, Endocrinology Unit, Austin Health, Heidelberg, Victoria, 3084, Australia. E-mail: r.macisaac{at}austin.unimelb.edu.au
Abstract
OBJECTIVE—To determine the prevalence and characteristics of patients with type 2 diabetes who have impaired renal function, defined as a glomerular filtration rate (GFR) <60 ml · min−1 · 1.73 m−2, and normoalbuminuria.
RESEARCH DESIGN AND METHODS—A cross-sectional survey of 301 outpatients attending a single tertiary referral center using the plasma disappearance of isotopic 99mTc-diethylene-triamine-penta-acetic acid to measure GFR and at least two measurements of urinary albumin excretion rate (AER) over 24 h to determine albuminuria.
RESULTS—A total of 109 patients (36%) had a GFR <60 ml · min−1 · 1.73 m−2. The overall prevalence of normo-, micro-, and macroalbuminuria was 43 of 109 (39%), 38 of 109 (35%), and 28 of 109 (26%), respectively. Compared with patients with macroalbuminuria, those with normoalbuminuria were more likely to be older and female. After excluding patients whose normoalbuminuric status was possibly related to the initiation of a renin-angiotensin system (RAS) inhibitor before the start of the study, the prevalence of a GFR <60 ml · min−1 · 1.73 m−2 and normoalbuminuria was 23%. Temporal changes in GFR in a subset of 34 of 109 (32%) unselected patients with impaired renal function were available for comparison over a 3- to 10-year period. The rates of decline in GFR (ml · min−1 · 1.73 m−2 · year−1) of −4.6 ± 1.0, −2.8 ± 1.0, and −3.0 ± 07 were not significantly different for normo- (n = 12), micro- (n = 12), and macroalbuminuric (n = 10) patients, respectively.
CONCLUSIONS—These results suggest that patients with type 2 diabetes can commonly progress to a significant degree of renal impairment while remaining normoalbuminuric.
- AER, albumin excretion rate
- CHD, coronary heart disease
- CVD, cerebrovascular disease
- DTPA, 99mTc-diethylene-triamine-penta-acetic acid
- GFR, glomerular filtration rate
- PVD, peripheral vascular disease
- RAS, renin-angiotensin system
- RIA, radioimmunoassay
Footnotes
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted October 5, 2003.
- Received March 11, 2003.
- DIABETES CARE














